Prime expert presents at “The Most Favored Nation Mandate” webinar - Prime Therapeutics
Prime expert presents at “The Most Favored Nation Mandate” webinar
George Van Antwerp, MBA, senior vice president of product innovation and strategic planning at Prime Therapeutics, will participate in Sept. 10 webinar “The Most Favored Nation Mandate: What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients”
The Trump administration’s Most Favored Nation (MFN) initiative may be one of the most transformative — and hotly debated — drug pricing policies in recent history. As stakeholders across the health care continuum prepare for its potential effects, the first of a three-part webinar series offers timely and essential perspectives on how MFN could impact health care, including:
Who may benefit, who may lose out and what’s next for this policy strategy.
Pharma’s response, potential legal challenges and industry pricing strategy.
Its impact on innovation, global markets and the U.S. first-to-launch status.
Its impact on pharmacy benefit manager (PBM) contracts, rebate structures and distribution models.
Patient access implications.
Event:
“The Most Favored Nation Mandate: What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients” webinar
Date/time:
Wednesday, Sept. 10, 2025 at 6 p.m. CT (7 p.m. ET)
Moderator:
Ned Milenkovich, PharmD, JD, chair of the health care practice at Much Shelist, P.C.
Speakers:
George Van Antwerp, MBA, senior vice president of product innovation and strategic planning at Prime Therapeutics
Brian Corvino, principal and global market access practice leader at Deloitte
Neal Masia, Ph.D., co-founder and chief executive officer at EntityRisk, Inc.
Ali Pashazadeh, founder, chairman and chief executive officer at Treehill Partners
About Prime Therapeutics
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.